SPONSOR
National Heart, Lung, and Blood Institute (NHLBI)
Total Trials
10
Recruiting
10
Phases
EARLY_Phase 1, Phase 1, Phase 2, Phase 2
Conditions studied: Chronic Lymphocytic Leukemia (CLL)Waldenstr(SqrRoot)(Delta)m s MacroglobulinemiaMantle Cell LymphomaSudden Cardiac DeathCardiac ArrhythmiasHematologic MalignanciesHealthy VolunteersCardiovascular DiseaseObesityMyeloid Chimerism
National Heart, Lung, and Blood Institute (NHLBI) is a clinical research sponsor with 10 registered studies on ClinicalTrials.gov, of which 10 are actively recruiting participants. Research covers conditions including Chronic Lymphocytic Leukemia (CLL), Waldenstr(SqrRoot)(Delta)m s Macroglobulinemia, Mantle Cell Lymphoma, Sudden Cardiac Death.
The trial portfolio spans EARLY_Phase 1, Phase 1, Phase 2, Phase 2 studies, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.
Frequently Asked Questions — National Heart, Lung, and Blood Institute (NHLBI)
How many clinical trials has National Heart, Lung, and Blood Institute (NHLBI) sponsored?
ClinicalMetric currently tracks 10 clinical trials sponsored by National Heart, Lung, and Blood Institute (NHLBI), of which 10 are actively recruiting participants. These trials cover conditions including Chronic Lymphocytic Leukemia (CLL), Waldenstr(SqrRoot)(Delta)m s Macroglobulinemia, Mantle Cell Lymphoma. Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.
What therapeutic areas does National Heart, Lung, and Blood Institute (NHLBI) research focus on?
National Heart, Lung, and Blood Institute (NHLBI) clinical trials span Chronic Lymphocytic Leukemia (CLL), Waldenstr(SqrRoot)(Delta)m s Macroglobulinemia, Mantle Cell Lymphoma, Sudden Cardiac Death, Cardiac Arrhythmias, and additional conditions. The research pipeline includes EARLY_Phase 1, Phase 1, Phase 2, Phase 2 trials, reflecting work from early-stage safety evaluation through large-scale efficacy studies.
How do I participate in a National Heart, Lung, and Blood Institute (NHLBI) clinical trial?
To participate in a National Heart, Lung, and Blood Institute (NHLBI) trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all National Heart, Lung, and Blood Institute (NHLBI) trials with current recruitment status updated daily.
Clinical Trials by National Heart, Lung, and Blood Institute (NHLBI)
NCT05724121
Recruiting
Observational Study of Cardiac Arrhythmias During Treatment With BTK Inhibitors or Venetoclax
Chronic Lymphocytic Leukemia (CLL)
NCT06615986 EARLY_Phase 1
Recruiting
Human Milk Oligosaccharide-Based Synbiotic Supplement for Intestinal Microbiota Dysbiosis
Healthy Volunteers
NCT01927783
Recruiting
Heart Health Study in Washington D.C. to Develop a Community-Based Behavioral Weight Loss Intervention
Cardiovascular Disease
NCT00442195
Recruiting
Collection and Analysis of Blood, Bone Marrow, and Buccal Mucosa Samples From Healthy Volunteers
Healthy Volunteers
NCT04008368 Phase 1, Phase 2
Recruiting
Repeat Peripheral Blood Stem Cell Transplantation for Patients With Sickle Cell Disease and Falling Donor Myeloid Chimerism Levels
Myeloid Chimerism
NCT01174108 Phase 2
Recruiting
Allogeneic Hematopoietic Stem Cell Transplantation for Severe Aplastic Anemia and Other Bone Marrow Failure Syndromes Using G-CSF Mobilized CD34+ Selected Hematopoietic Precursor Cells Co-Infused With a Reduced Dose of Non-Mobilized Donor T-cells
Severe Aplastic Anemia
NCT00001465
Recruiting
Study of the Disease Process of Lymphangioleiomyomatosis
Lung Disease
NCT06621511
Recruiting
OurSleepKit To Support CPAP Adherence
Obstructive Sleep Apnea
NCT03538639
Recruiting
Vascular Disease Discovery Protocol
Vascular Dysfunction
NCT06093867
Recruiting
Early Detection of Infectious and Noninfectious Lung Diseases Following Allogeneic Hematopoietic Stem Cell Transplantation
Allogeneic Hematopoietic Stem Cell Transplantation (HSCT)
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: September 2026 · Data Methodology